Fosun, said to be stymied by India's buyout rules, now aims for smaller Gland Pharma stake in $1.1B deal
admin 18th September 2017 Uncategorised 0Fosun seems determined to take control of India’s Gland Pharma. After its $1.26 billion deal for an 86% stake was reportedly struck down by India’s cabinet, the Chinese pharma has dialed down the offer to $1.1 billion for 74%. And that’s just enough to circumvent the Indian government’s scrutiny.
More: Fosun, said to be stymied by India's buyout rules, now aims for smaller Gland Pharma stake in .1B deal
Source: fierce